Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

ITV chair Cosslett tapped to chair Johnson Matthey

(Sharecast News) - Johnson Matthey announced the appointment of Andrew Cosslett as its new non-executive chair, effective immediately following the conclusion of its annual general meeting on Thursday. He was succeeding Patrick Thomas, who had stepped down from the board.

The FTSE 250 company said Cosslett, an experienced chair with a background in transformational change and shareholder value creation, would bring extensive leadership experience across sectors including consumer goods, hospitality, and media.

"I am delighted to welcome Andrew to Johnson Matthey as chair," said Liam Condon, chief executive of Johnson Matthey.

"He brings a wealth of experience and strategic perspectives with a clear focus on high performance, and I am confident he will provide strong leadership to the board and valuable support to the executive team as we deliver the next phase of our strategy."

He currently serves as chair of ITV and previously held senior roles at Kingfisher, the Rugby Football Union, InterContinental Hotels Group, and Fitness First.

"Johnson Matthey is a business with a proud heritage," commented Cosslett.

"I'm excited to join at such a pivotal time, with the sale of Catalyst Technologies to be completed and the business transitioning to focus on sustainable cash generation.

"I look forward to working with the team to deliver long-term value for all our stakeholders."

In a separate statement, ITV confirmed Cosslett's appointment as chair of Johnson Matthey.

He would also serve as chair of Johnson Matthey's nomination committee and sit on its societal value committee.

At 0912 BST, shares in Johnson Matthey were up 0.81% at 1,862p, while those in ITV were flat at 79.55p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.